KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Petmed Express (PETS) Long-Term Investments (2022)

Petmed Express has reported Long-Term Investments over the past 2 years, most recently at $5.0 million for Q2 2022.

For Q2 2022, Long-Term Investments changed N/A year-over-year to $5.0 million; the TTM value through Jun 2022 reached $5.0 million, changed N/A, while the annual FY2011 figure was $12.4 million, N/A changed from the prior year.
Long-Term Investments for Q2 2022 was $5.0 million at Petmed Express, up from $1.5 million in the prior quarter.
Over five years, Long-Term Investments peaked at $5.0 million in Q2 2022 and troughed at $5.0 million in Q2 2022.